CLL | Tumor

CURE’s Chronic Lymphocytic Leukemia (CLL) page features the latest cancer news and updates on CLL Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in chronic lymphocytic leukemia.

The Pathway of Cancer is Fraught with Anxiety

November 7th 2024, 6:00pm

Article

As a patient with chronic lymphocytic leukemia, I recently gleaned three new insights from my oncologist and phlebotomist.

Good Friends Make the Cancer Journey a Bit Easier

October 23rd 2024, 5:00pm

Article

Two dear friends have introduced helpful items to me, such as a chemo jacket since I became cold in the treatment room.

Jaypirca Plus Venclexta With or Without Rituxan May Be Beneficial in r/r CLL

October 10th 2024, 1:00pm

Article

A phase 1b trial showed promising results among patients with relapsed or refractory chronic lymphocytic leukemia.

Brukinsa Recommended Versus Imbruvica in R/R CLL, SLL

October 9th 2024, 3:00pm

Article

Patients with relapsed or refractory CLL or SLL may benefit from receiving Brukinsa instead of Imbruvica, as Brukinsa demonstrated superior effectiveness.

My Bitter Chemotherapy Pills for Chronic Lymphocytic Leukemia

October 7th 2024, 5:00pm

Article

I’ve recently started on chemotherapy pills instead of infusions and the bitterness reminds me to accept not only the bitterness of the pill, but in life too.

Mike Peters of the Alarm in Remission, Broadway Star Gavin Creel Dies and More

October 4th 2024, 3:00pm

Article

From good news for a rock star to the deaths of stage and screen stars, here’s what’s happening in the cancer space this week.

The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration

September 20th 2024, 12:59pm

Video

The discussion will wrap up with perspectives on the future of CLL treatment, including anticipated improvements in patient care and quality of life, emerging therapies, and evolving patient roles in care decisions.

Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors

September 20th 2024, 12:57pm

Video

The discussion will explore the impact of fixed-duration treatments on quality of life, benefits and challenges compared with continuous therapy, financial considerations, and lifestyle goals during and after treatment.

Treatment Switching May Be Less Likely With Brukinsa vs Other BTK Inhibitors in CLL/SLL

September 17th 2024, 1:00pm

Article

Treatment with Brukinsa may lower the rates of switching therapies compared with Calquence and Imbruvica in chronic lymphocytic leukemia.

Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs

September 13th 2024, 2:54pm

Video

The discussion will cover fixed-duration treatments vs continuous therapy for CLL and provide a brief overview of venetoclax-based regimens approved for 12 cycles with obinutuzumab and 24 cycles with rituximab.